$LFVN
Lifevantage Corp Stock $lfvn

$lfvn Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000144530513001238 Filed on May 09, 2013

Income Statement

Concept	2013 Q2	2013 Q1	2012 Q1
Revenue	$51.51M	$50.37M	$36.21M
YoY Change	15.49%	39.1%	262.85%
Cost Of Revenue	$7.290M	$7.330M	$4.989M
YoY Change	13.37%	46.92%	215.76%
Gross Profit	$44.22M	$43.50M	$31.22M
YoY Change	15.83%	39.32%	272.15%
Gross Profit Margin	85.85%	86.36%	86.22%
Selling, General & Admin	$42.66M	$38.21M	$24.29M
YoY Change	41.21%	57.31%	226.94%
% of Gross Profit	96.47%	87.85%	77.8%
Research & Development	$840.0K	$848.0K	$378.0K
YoY Change	95.35%	124.34%	215.0%
% of Gross Profit	1.9%	1.95%	1.21%
Depreciation & Amortization	$480.0K	$499.0K	$146.0K
YoY Change	140.0%	241.78%	143.33%
% of Gross Profit	1.09%	1.15%	0.47%
Operating Expenses	$43.98M	$39.56M	$24.82M
YoY Change	42.61%	59.42%	226.53%
Operating Profit	$242.0K	$3.940M	$6.407M
YoY Change	-96.7%	-38.5%	711.01%
Interest Expense	-$840.0K	-$270.0K	-$10.67M
YoY Change	1580.0%	-97.47%	1.04%
% of Operating Profit	-347.11%	-6.85%	-166.54%
Other Income/Expense, Net	$350.0K	$122.0K	-$10.67M
YoY Change		-101.14%
Pretax Income	-$250.0K	$4.062M	-$4.259M
YoY Change	-103.43%	-195.37%	-56.41%
Income Tax	-$60.00K	$646.0K	$587.0K
% Of Pretax Income		15.9%
Net Earnings	-$182.0K	$3.416M	-$4.846M
YoY Change	-103.77%	-170.49%	-50.4%
Net Earnings / Revenue	-0.35%	6.78%	-13.38%
Basic Earnings Per Share	$0.00	$0.03	-$0.05
Diluted Earnings Per Share	$0.00	$0.03	-$0.05
COMMON SHARES
Basic Shares Outstanding	113.5M shares	112.8M shares	103.0M shares
Diluted Shares Outstanding		125.0M shares	103.0M shares

Balance Sheet

Concept	2013 Q2	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.30M	$27.24M	$16.90M
YoY Change	6.69%	61.18%	286.73%
Cash & Equivalents	$26.30M	$27.24M	$16.90M
Short-Term Investments			$0.00
Other Short-Term Assets	$5.180M	$7.230M	$4.190M
YoY Change	108.03%	72.55%	544.62%
Inventory	$10.52M	$8.025M	$6.980M
Prepaid Expenses
Receivables	$1.789M	$1.381M	$820.0K
Other Receivables	$2.150M	$0.00	$0.00
Total Short-Term Assets	$45.94M	$43.87M	$28.88M
YoY Change	18.32%	51.92%	295.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.692M	$5.926M	$1.770M
YoY Change	185.03%	234.8%	785.0%
Goodwill
YoY Change
Intangibles	$1.747M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.374M	$2.900M	$820.0K
YoY Change	-24.51%	253.66%	2633.33%
Total Long-Term Assets	$9.543M	$10.61M	$4.500M
YoY Change	67.42%	135.67%	98.24%
TOTAL ASSETS
Total Short-Term Assets	$45.94M	$43.87M	$28.88M
Total Long-Term Assets	$9.543M	$10.61M	$4.500M
Total Assets	$55.48M	$54.48M	$33.38M
YoY Change	24.6%	63.21%	248.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.171M	$4.608M	$0.00
YoY Change	43.04%		-100.0%
Accrued Expenses	$14.62M	$12.85M	$9.910M
YoY Change	34.75%	29.67%	231.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$20.57M	$18.58M	$10.77M
YoY Change	28.31%	72.52%	-15.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$973.0K	$1.042M	$80.00K
YoY Change	348.39%	1202.5%	-99.2%
Total Long-Term Liabilities	$973.0K	$1.042M	$80.00K
YoY Change	348.39%	1202.5%	-99.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.57M	$18.58M	$10.77M
Total Long-Term Liabilities	$973.0K	$1.042M	$80.00K
Total Liabilities	$21.54M	$19.62M	$10.85M
YoY Change	32.59%	80.85%	-52.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$76.48M	-$74.06M
YoY Change	-0.63%
Common Stock	$110.5M	$109.0M
YoY Change	5.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.95M	$34.86M	$22.53M
YoY Change
Total Liabilities & Shareholders Equity	$55.48M	$54.48M	$33.38M
YoY Change	24.6%	63.21%	248.8%

Cashflow Statement

Concept	2013 Q2	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$182.0K	$3.416M	-$4.846M
YoY Change	-103.77%	-170.49%	-50.4%
Depreciation, Depletion And Amortization	$480.0K	$499.0K	$146.0K
YoY Change	140.0%	241.78%	143.33%
Cash From Operating Activities	$590.0K	$3.710M	$3.630M
YoY Change	-92.36%	2.2%	170.9%
INVESTING ACTIVITIES
Capital Expenditures	-$450.0K	-$760.0K	-$740.0K
YoY Change	-2.17%	2.7%	2366.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$450.0K	-$760.0K	-$740.0K
YoY Change	-2.17%	2.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.190M	-4.090M	640.0K
YoY Change	-358.7%	-739.06%	1180.0%
NET CHANGE
Cash From Operating Activities	590.0K	3.710M	3.630M
Cash From Investing Activities	-450.0K	-760.0K	-740.0K
Cash From Financing Activities	-1.190M	-4.090M	640.0K
Net Change In Cash	-1.050M	-1.140M	3.530M
YoY Change	-113.6%	-132.29%	153.96%
FREE CASH FLOW
Cash From Operating Activities	$590.0K	$3.710M	$3.630M
Capital Expenditures	-$450.0K	-$760.0K	-$740.0K
Free Cash Flow	$1.040M	$4.470M	$4.370M
YoY Change	-87.29%	2.29%	218.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Inventory Recall Expense InventoryRecallExpense	0	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1381000	USD
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	333000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4608000	USD
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3615000	USD
CY2012Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2287000	USD
CY2013Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	100000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-45000	USD
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21000	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	108850000	USD
CY2012Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	105154000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1600000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	881000	USD
CY2012Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	308000	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	585000	USD
CY2012Q2	us-gaap	Assets Assets	44528000	USD
CY2013Q1	us-gaap	Assets Assets	54479000	USD
CY2012Q2	us-gaap	Assets Current AssetsCurrent	38828000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	43874000	USD
	us-gaap	Business Development BusinessDevelopment	-363000	USD
	us-gaap	Business Development BusinessDevelopment	0	USD
CY2012Q1	us-gaap	Business Development BusinessDevelopment	0	USD
CY2013Q1	us-gaap	Business Development BusinessDevelopment	-363000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27239000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24648000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16896000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6371000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10525000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2591000	USD
CY2012Q2	us-gaap	Commissions Payable To Broker Dealers And Clearing Organizations CommissionsPayableToBrokerDealersAndClearingOrganizations	5631000	USD
CY2013Q1	us-gaap	Commissions Payable To Broker Dealers And Clearing Organizations CommissionsPayableToBrokerDealersAndClearingOrganizations	7201000	USD
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	110174000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113464000	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110174000	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113464000	shares
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	111000	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	116000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4926000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	3329000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	7649000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	7766000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company discloses significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2013</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$17.5 million</font><font style="font-family:inherit;font-size:10pt;"> in cash accounts that were held primarily at one financial institution and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> in an account at another financial institution. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2012</font><font style="font-family:inherit;font-size:10pt;"> the Company’s cash balances exceeded federally insured limits</font></div></div>
CY2012Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4989000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11625000	USD
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7330000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23936000	USD
CY2013Q1	us-gaap	Customer Deposits Current CustomerDepositsCurrent	228000	USD
CY2012Q2	us-gaap	Customer Deposits Current CustomerDepositsCurrent	154000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2712000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1244000	USD
CY2012Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1244000	USD
CY2012Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1479000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1479000	USD
CY2013Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1419000	USD
CY2012Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	342000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	146000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	499000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1180000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	323000	USD
CY2012Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-10687000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6741000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2013Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-24000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	12000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.3536
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3438
CY2012Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1882000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1781000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-926000	USD
CY2012Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	3000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-24000	USD
CY2013Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-379000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-6741000	USD
CY2012Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-10687000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2013Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8370000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10492000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23227000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4616000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	43501000	USD
	us-gaap	Gross Profit GrossProfit	69954000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	31223000	USD
	us-gaap	Gross Profit GrossProfit	127313000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4062000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4259000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11399000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7386000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3609000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	646000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	587000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-251000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2280000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	6370000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	993000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-799000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1048000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-125000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6097000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1485000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	0	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	74000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1077000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	827000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4856000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4735000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1771000	USD
CY2012Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5964000	USD
CY2013Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3093000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	8025000	USD
CY2012Q2	us-gaap	Inventory Net InventoryNet	11353000	USD
CY2012Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	5389000	USD
CY2013Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4932000	USD
	us-gaap	Inventory Recall Expense InventoryRecallExpense	5418000	USD
CY2013Q1	us-gaap	Inventory Recall Expense InventoryRecallExpense	-461000	USD
CY2012Q2	us-gaap	Liabilities Liabilities	16245000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	19622000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54479000	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44528000	USD
CY2012Q1	us-gaap	Inventory Recall Expense InventoryRecallExpense	0	USD
CY2012Q4	us-gaap	Inventory Write Down InventoryWriteDown	3700000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18580000	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16028000	USD
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2012 the Company initiated a voluntary recall of specific lots of Protandim</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">.  On December 31, 2012, the Company recorded </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.9 million</font><font style="font-family:inherit;font-size:10pt;"> in costs related to the recall. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2013</font><font style="font-family:inherit;font-size:10pt;"> the Company has recorded a total net expense of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">. The costs recorded for the recall include initial cost recoveries from insurance of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$511,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2827000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	290000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4625000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1443000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11666000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10067000	USD
	us-gaap	Net Income Loss NetIncomeLoss	7637000	USD
	us-gaap	Net Income Loss NetIncomeLoss	7790000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	3416000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-4846000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	376000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6732000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	122000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-426000	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10666000	USD
	us-gaap	Operating Expenses OperatingExpenses	55836000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	24816000	USD
	us-gaap	Operating Expenses OperatingExpenses	115488000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	39561000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	11825000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	6407000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	14118000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3940000	USD
CY2012Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2932000	USD
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5552000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1042000	USD
CY2012Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	217000	USD
CY2012Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	122000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-426000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	976000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4893000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	49000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1744000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4625000	USD
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2012Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-434000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	350000	USD
	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	0	USD
	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	4155000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5926000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1997000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	924000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2105000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	378000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	848000	USD
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-76961000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74064000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	36212000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	50370000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	156667000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	81579000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	88976000	USD
CY2012Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19676000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29844000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	44097000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1635000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	881000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.27
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.37
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0119
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0097
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0046
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0093
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1500000	shares
CY2013Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	957000	shares
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1635000	USD
CY2013Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2000000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4893000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	28283000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	34857000	USD
CY2012Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	546000	USD
CY2013Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	70000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management has made a number of estimates and assumptions relating to the reporting of revenues, expenses, assets and liabilities and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements. Actual results could differ from those estimates.</font></div></div>
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	124985000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115232000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103016000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125371000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103016000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100451000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112806000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	112203000	shares
CY2012Q1	lfvn	Common Shares Issuable Upon Exercise Of Warrants Or Rights CommonSharesIssuableUponExerciseOfWarrantsOrRights	120000	shares
CY2013Q1	lfvn	Common Shares Issuable Upon Exercise Of Warrants Or Rights CommonSharesIssuableUponExerciseOfWarrantsOrRights	710000	shares
CY2012Q1	lfvn	Derivative Instruments Realized Gain Loss Net DerivativeInstrumentsRealizedGainLossNet	0	USD
	lfvn	Derivative Instruments Realized Gain Loss Net DerivativeInstrumentsRealizedGainLossNet	112000	USD
	lfvn	Derivative Instruments Realized Gain Loss Net DerivativeInstrumentsRealizedGainLossNet	0	USD
CY2013Q1	lfvn	Derivative Instruments Realized Gain Loss Net DerivativeInstrumentsRealizedGainLossNet	112000	USD
	lfvn	Increase Decrease In Other Long Term Liabilities IncreaseDecreaseInOtherLongTermLiabilities	0	USD
	lfvn	Increase Decrease In Other Long Term Liabilities IncreaseDecreaseInOtherLongTermLiabilities	442000	USD
	lfvn	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	1703000	USD
	lfvn	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	2066000	USD
CY2013Q1	lfvn	Other Accrued Operating Liabilities Current OtherAccruedOperatingLiabilitiesCurrent	2300000	USD
CY2012Q2	lfvn	Other Accrued Operating Liabilities Current OtherAccruedOperatingLiabilitiesCurrent	939000	USD
	lfvn	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease Excluding Sale Of Subsidiary Amount OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseExcludingSaleOfSubsidiaryAmount	-24000	USD
	lfvn	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease Excluding Sale Of Subsidiary Amount OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseExcludingSaleOfSubsidiaryAmount	12000	USD
CY2012Q1	lfvn	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease Excluding Sale Of Subsidiary Amount OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseExcludingSaleOfSubsidiaryAmount	-80000	USD
CY2013Q1	lfvn	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease Excluding Sale Of Subsidiary Amount OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseExcludingSaleOfSubsidiaryAmount	-87000	USD
CY2013Q1	lfvn	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease Excluding Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseExcludingNoncontrollingInterest	-87000	USD
	lfvn	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease Excluding Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseExcludingNoncontrollingInterest	-24000	USD
CY2012Q1	lfvn	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease Excluding Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseExcludingNoncontrollingInterest	-80000	USD
	lfvn	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease Excluding Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseExcludingNoncontrollingInterest	12000	USD
CY2013Q1	lfvn	Other Income Expense Net OtherIncomeExpenseNet	26000	USD
CY2012Q1	lfvn	Other Income Expense Net OtherIncomeExpenseNet	18000	USD
	lfvn	Other Income Expense Net OtherIncomeExpenseNet	25000	USD
	lfvn	Other Income Expense Net OtherIncomeExpenseNet	33000	USD
CY2013Q1	lfvn	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	5985000	USD
CY2012Q2	lfvn	Prepaid Expenses And Deposits PrepaidExpensesAndDeposits	1250000	USD
CY2013Q1	lfvn	Reserve For Sales Returns ReserveForSalesReturns	821000	USD
CY2012Q2	lfvn	Reserve For Sales Returns ReserveForSalesReturns	863000	USD
	lfvn	Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Shares Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockSharesGrantsInPeriod	1700000	shares
CY2012Q1	lfvn	Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Shares Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockSharesGrantsInPeriod	1800000	shares
	lfvn	Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Shares Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockSharesGrantsInPeriod	1900000	shares
CY2013Q1	lfvn	Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Shares Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockSharesGrantsInPeriod	1000000	shares
	lfvn	Stock Issued During Period Shares Stock Warrants Exercised StockIssuedDuringPeriodSharesStockWarrantsExercised	3777000	shares
CY2013Q1	lfvn	Stock Issued During Period Shares Stock Warrants Exercised StockIssuedDuringPeriodSharesStockWarrantsExercised	657000	shares
	lfvn	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	2066000	USD
	lfvn	Stock Options StockOptions	4586000	shares
CY2012Q1	lfvn	Stock Options StockOptions	0	shares
	lfvn	Stock Options StockOptions	4772000	shares
CY2013Q1	lfvn	Stock Options StockOptions	3802000	shares
	lfvn	Warrant Issued WarrantIssued	8582000	shares
CY2013Q1	lfvn	Warrant Issued WarrantIssued	8377000	shares
	lfvn	Warrant Issued WarrantIssued	10009000	shares
CY2012Q1	lfvn	Warrant Issued WarrantIssued	0	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000849146
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113524045	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	LIFEVANTAGE CORPORATION
	dei	Trading Symbol TradingSymbol	LFVN

Files In Submission

Name	View Source	Status
0001445305-13-001238-index-headers.html	Edgar Link	pending
0001445305-13-001238-index.html	Edgar Link	pending
0001445305-13-001238.txt	Edgar Link	pending
0001445305-13-001238-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
lfvn-20130331.xml	Edgar Link	completed
lfvn-20130331.xsd	Edgar Link	pending
lfvn-20130331_cal.xml	Edgar Link	unprocessable
lfvn-20130331_def.xml	Edgar Link	unprocessable
lfvn-20130331_lab.xml	Edgar Link	unprocessable
lfvn-20130331_pre.xml	Edgar Link	unprocessable
lfvn_033113x10q.htm	Edgar Link	pending
lfvn_033113xex311.htm	Edgar Link	pending
lfvn_033113xex312.htm	Edgar Link	pending
lfvn_033113xex321.htm	Edgar Link	pending
lfvn_033113xex322.htm	Edgar Link	pending
lfvn_33113xex101.htm	Edgar Link	pending
lfvn_33113xex102.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
redactedjenkonlicense_image6.gif	Edgar Link	pending
redactedjenkonservice_image1.gif	Edgar Link	pending
redactedjenkonservice_image2.gif	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFVN
Lifevantage Corp Stock $lfvn

2013 Q2 Form 10-Q Financial Statement

#000144530513001238 Filed on May 09, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN Lifevantage Corp Stock $lfvn

2013 Q2 Form 10-Q Financial Statement

#000144530513001238 Filed on May 09, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN
Lifevantage Corp Stock $lfvn